Efficacy and safety of cangrelor on top of anticoagulation in patients with myocardial infarction related cardiogenic shock or cardiac arrest receiving va ecmo: preliminary data from a phase 2 trial

View at publisher Summarise with VIRAT
Authors: M. Pieri, L Baldetti, Pasquale Nardelli, L. Zaccaria, Alessandro Ortalda, Savino Altizio, S Delrio, Evgeny V. Fominskiy, Alberto Zangrillo, Silvia Ajello, Anna Mara Scandroglio
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Introduction In Out-of-Hospital Cardiac Arrest (OHCA)/Acute Myocardial Infarction– Cardiogenic Shock (AMI-CS) requiring primary PCI and Veno-Arterial ExtraCorporeal Membrane Oxygenation (VA-ECMO), antithrombotic therapy is challenging due to competing thrombotic and bleeding risks and post-OHCA coagulopathy with associated platelet dysfunction. Early clinical data suggest that combination of a individually tailored Cangrelor dosing regimen based on Multiplate test results, combined with background bivalirudin anticoagulation, may be equally effective but safer in terms of bleeding risk than triple therapy (acetylsalicylic acid, P2Y12 inhibitor and anticoagulation) in this setting (1). We designed the SURVIVE phase-2, single-arm prospective clinical trial to assess efficacy and safety of a reduced, adjustable-dose Cangrelor regimen plus Bivalirudin in patients with OHCA and AMI-CS requiring VA-ECMO. Efficacy and safety endpoints were defined as thrombotic and bleeding (BARC ≥3b) adverse events occurring during Cangrelor infusion. Methods We report data from the first 5 consecutive OHCA-AMI-CS patients requiring VA-ECMO and who underwent pPCI treated with reduced, tailored Cangrelor dose (starting dose: 0.125 μg/kg/min without initial bolus) targeting an ADP test value

Fields of Study & Subjects

Antiplatelet Therapy and Cardiovascular Diseases Mechanical Circulatory Support Devices Acute Myocardial Infarction Research

Publication details

Journal / source
European Heart Journal Supplements
Volume
28
Issue
Supplement_3
Publication date
1 March 2026
Language
EN